Although Kraetsch et al. revealed significant improvement in the clinical and laboratory outcomes in 6 AOSD patients receiving infliximab therapy [149], a recent evidence-based review showed that TNF-α inhibitors might not be effective in AOSD treatment [137]. This evidence concerns the gene TNF and adult-onset Still disease.